Abstract
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/151622911
Article citations
Successful Treatment of Cutaneous Squamous Cell Cancer with Cemiplimab-A Report of Two Cases Demonstrating the Management of Pseudoprogression and Adverse Events.
J Clin Med, 13(14):4236, 19 Jul 2024
Cited by: 0 articles | PMID: 39064276 | PMCID: PMC11278102
Neoadjuvant Cemiplimab Followed by Radiation for Locally Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: A Case Report.
Adv Radiat Oncol, 9(8):101529, 27 Apr 2024
Cited by: 0 articles | PMID: 38993195
Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma of the Scalp: An Algorithm for Reconstruction and Treatment.
J Clin Med, 13(6):1581, 10 Mar 2024
Cited by: 0 articles | PMID: 38541808 | PMCID: PMC10971407
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
Lancet Oncol, 21(2):294-305, 14 Jan 2020
Cited by: 174 articles | PMID: 31952975 | PMCID: PMC7771329
Efficacy of Cemiplimab as Adjuvant or Neoadjuvant Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma.
Ann Plast Surg, 92(4s suppl 2):S129-S131, 01 Apr 2024
Cited by: 0 articles | PMID: 38556660
Cemiplimab in cutaneous squamous cell carcinomas (SCC): an overview and a clinical case.
Oral Oncol, 128:105847, 31 Mar 2022
Cited by: 3 articles | PMID: 35367788
Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma.
Expert Opin Drug Saf, 21(1):21-29, 01 Nov 2021
Cited by: 20 articles | PMID: 34644510
Review